‘Remdesivir’ New POSSIBLE CURE Worked On, US Officials Believes But China Claims it Can’t Reduce Death Rate


    The world has been tragically affected by the spreading coronavirus pandemic, and as of now, more than three million people have already been infected with the deadly virus. The developed countries are working to find a cure to treat the deadly virus and have already tested various antiviral, antimalarial, antibiotic, and antiretroviral to prevent the coronavirus pandemic.

    Scientists from all around the world and the World Health Organization recently considered a drug, named a remdesivir among all other as promising medicine to cure pandemic. Dr. Anthony Fauci, an infectious disease expert in the United States, claimed that the drug has a clear cut and positive effect in curing the virus.

    The medicine, remdesivir is a broad-spectrum antiviral developed by US pharmaceutical company Gilead initially to cure the patients of the Ebola virus, a decade ago. The drug was widely accepted in those countries where the Ebola virus was rapidly spreading. The researchers even tested the drug in animals after injecting the viruses of Middle East Respiratory Syndrome (Mers-CoV), and the results looked promising.

    The medicine is currently used for only clinical trials as the health authorities haven’t approved the use of this drug. But, the worst affected countries of the pandemic have requested Gilead to supply the drug.

    National Institute of Allergy and Infectious Diseases in the US, supported to find the cure with the help of remdesivir and more than 1000 patients were administrated with this drug. The result, however, improved the condition of patients at an average of 11 days, but there wasn’t any significant change in survival rate.

    China also conducted a study regarding the usage of remdesivir medicine and concluded that the drug could not reduce mortality rate or provide any speedy recovery for the patients suffering from COVID-19. However, the study was concluded citing the study must be done on a more substantial number of patients as the study taken was performed on a comparatively small number of patients—about 200.


    Please enter your comment!
    Please enter your name here